Prebiotic fructans have greater impact on luminal microbiology and CD3+ T cells in healthy siblings than patients with Crohn’s disease: a pilot study investigating the potential for primary prevention of inflammatory bowel disease
dc.contributor.author | Hedin, CR | |
dc.contributor.author | McCarthy, NE | |
dc.contributor.author | Louis, P | |
dc.contributor.author | Farquharson, FM | |
dc.contributor.author | McCartney, S | |
dc.contributor.author | Stagg, AJ | |
dc.contributor.author | Lindsay, JO | |
dc.contributor.author | Whelan, K | |
dc.date.accessioned | 2021-07-19T15:47:04Z | |
dc.date.available | 2021-07-19T15:47:04Z | |
dc.date.issued | 2021-06-01 | |
dc.identifier.issn | 0261-5614 | |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/73127 | |
dc.relation.ispartof | Clinical Nutrition | |
dc.title | Prebiotic fructans have greater impact on luminal microbiology and CD3+ T cells in healthy siblings than patients with Crohn’s disease: a pilot study investigating the potential for primary prevention of inflammatory bowel disease | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1016/j.clnu.2021.05.033 | |
pubs.notes | Not known | en_US |
Files in this item
This item appears in the following Collection(s)
-
Centre for Immunobiology [1099]